Discovery of small molecule VEGFR-2 inhibitors with preferential ocular distribution and retention following oral dosing

被引:0
|
作者
Meredith, Erik [1 ]
Mainolfi, Nello [1 ]
Poor, Stephen [1 ]
Qiu, Yubin [1 ]
Miranda, Karl [1 ]
Powers, James [1 ]
Liu, Donglei [1 ]
Ma, Fupeng [1 ]
Solovay, Catherine [1 ]
Rao, Chang [1 ]
Johnson, Leland [1 ]
Ji, Nan [1 ]
Artman, Gerald [1 ]
Hardegger, Leo [1 ]
Hanks, Shawn [1 ]
Shen, Siyuan [1 ]
Woolfenden, Amber [1 ]
Fassbender, Elizabeth [1 ]
Sivak, Jeremy [1 ]
Zhang, Yiqin [1 ]
Long, Debby [1 ]
Cepeda, Rosemarie [1 ]
Hosagrahara, Vinayak [1 ]
Lee, Wendy [1 ]
Tarsa, Peter [1 ]
Liu, Fang [1 ]
Anderson, Karen [1 ]
Newton, Ronald [1 ]
End, Peter [1 ]
Elliott, Jason [1 ]
Jaffee, Bruce [1 ]
机构
[1] Novartis Inst Biomed Res, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
269
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration
    Meredith, Erik L.
    Mainolfi, Nello
    Poor, Stephen
    Qiu, Yubin
    Miranda, Karl
    Powers, James
    Liu, Donglei
    Ma, Fupeng
    Solovay, Catherine
    Rao, Chang
    Johnson, Leland
    Ji, Nan
    Artman, Gerald
    Hardegger, Leo
    Hanks, Shawn
    Shen, Siyuan
    Woolfenden, Amber
    Fassbender, Elizabeth
    Sivak, Jeremy M.
    Zhang, Yiqin
    Long, Debby
    Cepeda, Rosemarie
    Liu, Fang
    Hosagrahara, Vinayak P.
    Lee, Wendy
    Tarsa, Peter
    Anderson, Karen
    Elliott, Jason
    Jaffee, Bruce
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (23) : 9273 - 9286
  • [2] Discovery of Novel Pyrimidine Based Small Molecule Inhibitors as VEGFR-2 Inhibitors: Design, Synthesis, and Anti-Cancer Studies
    Dhawale, Sachin A.
    Mokale, Santosh N.
    Dabhade, Pratap S.
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2025, 21 (01) : 38 - 49
  • [3] Recent updates on potential of VEGFR-2 small-molecule inhibitors as anticancer agents
    Chaudhari, Prashant Jagannath
    Nemade, Aditya Ramchandra
    Shirkhedkar, Atul Arun
    RSC ADVANCES, 2024, 14 (45) : 33384 - 33417
  • [4] Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy
    Chekler, Eugene L. Piatnitski
    Kiselyov, Alexander S.
    Ouyang, Xiaohu
    Chen, Xiaoling
    Pattaropong, Vatee
    Wang, Ying
    Tuma, M. Carolina
    Doody, Jacqueline F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (09): : 488 - 492
  • [5] From Deep Learning to the Discovery of Promising VEGFR-2 Inhibitors
    Yucel, Mehmet Ali
    Adal, Ercan
    Aktekin, Mine Buga
    Hepokur, Ceylan
    Gambacorta, Nicola
    Nicolotti, Orazio
    Algul, Oztekin
    CHEMMEDCHEM, 2024, 19 (16)
  • [6] Optimizing intermittent dosing of oral small molecule inhibitors
    Yun, Jina
    Indorf, Amy Ly
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025,
  • [7] Research progress of VEGFR small molecule inhibitors in ocular neovascular diseases
    Jiang, Die
    Xu, Ting
    Zhong, Lei
    Liang, Qi
    Hu, Yonghe
    Xiao, Wenjing
    Shi, Jianyou
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 257
  • [8] Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase Inhibitors
    Lv, Yongcong
    Li, Mengyuan
    Liu, Ting
    Tong, Linjiang
    Peng, Ting
    Wei, Lixin
    Ding, Jian
    Xie, Hua
    Duan, Wenhu
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (05): : 592 - 597
  • [9] Discovery of anilinopyrimidine-based naphthamide derivatives as potent VEGFR-2 inhibitors
    Lv, Yongcong
    Li, Mengyuan
    Cao, Sufen
    Tong, Linjiang
    Peng, Ting
    Wei, Lixin
    Xie, Hua
    Ding, Jian
    Duan, Wenhu
    MEDCHEMCOMM, 2015, 6 (07) : 1375 - 1380
  • [10] Protein-ligand interaction-guided discovery of novel VEGFR-2 inhibitors
    Zhang, Yanmin
    Zhang, Mingliang
    Wang, Yuchen
    Fan, Yuanrong
    Chen, Xingye
    Yang, Yan
    Hua, Yi
    Xie, Wuchen
    Lu, Tao
    Tang, Weifang
    Chen, Yadong
    Liu, Haichun
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (09): : 2559 - 2574